Literature DB >> 28747261

Enterovirus D68 infection in a cluster of children with acute flaccid myelitis, Buenos Aires, Argentina, 2016.

Victor Ruggieri1, Maria Ivana Paz2, María Gabriela Peretti2, Carlos Rugilo3, Rosa Bologna4, Cecilia Freire5, Silvana Vergel2, Andrea Savransky2.   

Abstract

OBJECTIVE: To report a outbreak of 11 cases of acute asymmetric flaccid myelopathy due to spinal motor neuron injury.
MATERIAL AND METHODS: Eleven children, six male, with a mean age of 3 years presented with acute flaccid myelitis. We analyzed clinical features, etiology, neuroradiological images, treatment, and outcome.
RESULTS: Nine children had bilateral and asymmetric flaccid myelitis of the upper limbs, 1 had upper limb monoplegia, and 1 presented with hemiparesis. The cranial nerves were involved in 6 patients and 4 required mechanical ventilation. In all cases acute flaccid myelitis co-occurred with upper airway infection and/or fever. Spinal cord magnetic resonance imaging was abnormal in all, showing 2 different patterns: A linear pattern involving the anterior horns and another that was more heterogeneous showing spinal cord expansion. The lesions were non-enhancing in all. In 5/11 patients involvement of the medulla oblongata and pons was also observed. None of the patients presented with supratentorial lesions. In 4/11 children, the human enterovirus subtype D68 (HEV-D68) was identified in the airway and in 1/11 in the cerebrospinal fluid as well. In the remaining patients different enterovirus species A, B, and C variants were detected, as well as rhinovirus in 1 and influenza in another. Ten children received treatment with intravenous immunoglobulin and steroids and 4 of these children also underwent plasma exchange. Treatment did not lead to clinical improvement.
CONCLUSIONS: In a patient with acute flaccid myelitis, HEV-D68 infection should be ruled out. Cases in which the virus was not detected were considered as "false negatives" as samples were collected late in course of the disease. The lack of response to anti-inflammatory and immunomodulatory treatment suggests a direct viral mechanism. This study is to our knowledge the first on an HEV-D68-infection-related cluster in Latin America.
Copyright © 2017 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute flaccid myelitis; Acute myelopathy; Enterovirus-D68; Poliomyelitis

Mesh:

Year:  2017        PMID: 28747261     DOI: 10.1016/j.ejpn.2017.07.008

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  25 in total

1.  Clinical Subpopulations in a Sample of North American Children Diagnosed With Acute Flaccid Myelitis, 2012-2016.

Authors:  Matthew J Elrick; Eliza Gordon-Lipkin; Thomas O Crawford; Keith Van Haren; Kevin Messacar; Nicole Thornton; Elizabeth Dee; Annie Voskertchian; Jessica R Nance; Laura S Muñoz; Mark P Gorman; Leslie A Benson; David L Thomas; Carlos A Pardo; Aaron M Milstone; Priya Duggal
Journal:  JAMA Pediatr       Date:  2019-02-01       Impact factor: 16.193

Review 2.  Acute Flaccid Myelitis: Etiologic Challenges, Diagnostic and Management Considerations.

Authors:  Sarah E Hopkins
Journal:  Curr Treat Options Neurol       Date:  2017-11-28       Impact factor: 3.598

Review 3.  Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality.

Authors:  Kevin Messacar; Edwin J Asturias; Alison M Hixon; Coretta Van Leer-Buter; Hubert G M Niesters; Kenneth L Tyler; Mark J Abzug; Samuel R Dominguez
Journal:  Lancet Infect Dis       Date:  2018-02-23       Impact factor: 25.071

Review 4.  Acute flaccid myelitis: cause, diagnosis, and management.

Authors:  Olwen C Murphy; Kevin Messacar; Leslie Benson; Riley Bove; Jessica L Carpenter; Thomas Crawford; Janet Dean; Roberta DeBiasi; Jay Desai; Matthew J Elrick; Raquel Farias-Moeller; Grace Y Gombolay; Benjamin Greenberg; Matthew Harmelink; Sue Hong; Sarah E Hopkins; Joyce Oleszek; Catherine Otten; Cristina L Sadowsky; Teri L Schreiner; Kiran T Thakur; Keith Van Haren; Carolina M Carballo; Pin Fee Chong; Amary Fall; Vykuntaraju K Gowda; Jelte Helfferich; Ryutaro Kira; Ming Lim; Eduardo L Lopez; Elizabeth M Wells; E Ann Yeh; Carlos A Pardo
Journal:  Lancet       Date:  2020-12-23       Impact factor: 79.321

5.  Acute Flaccid Myelitis in Children in Zhejiang Province, China.

Authors:  Liming Gong; Yilong Wang; Weiqing Zhang; Chen Chen; Xinghui Yang; Lu Xu; Congying Zhao; Lihua Jiang; Zhefeng Yuan; Zhezhi Xia; Peifang Jiang; Qiong Ge; Juying Yan; Yi Sun; Yin Chen; Zhengyan Zhao; Yanjun Zhang; Feng Gao
Journal:  Front Neurol       Date:  2020-05-22       Impact factor: 4.003

6.  Twenty-nine Cases of Enterovirus-D68-associated Acute Flaccid Myelitis in Europe 2016: A Case Series and Epidemiologic Overview.

Authors:  Marjolein Knoester; Jelte Helfferich; Randy Poelman; Coretta Van Leer-Buter; Oebele F Brouwer; Hubert G M Niesters
Journal:  Pediatr Infect Dis J       Date:  2019-01       Impact factor: 2.129

7.  A Mouse Model of Enterovirus D68 Infection for Assessment of the Efficacy of Inactivated Vaccine.

Authors:  Chao Zhang; Xueyang Zhang; Wenlong Dai; Qingwei Liu; Pei Xiong; Shuxia Wang; Lanlan Geng; Sitang Gong; Zhong Huang
Journal:  Viruses       Date:  2018-01-30       Impact factor: 5.048

8.  Mapping Attenuation Determinants in Enterovirus-D68.

Authors:  Ming Te Yeh; Sara Capponi; Adam Catching; Simone Bianco; Raul Andino
Journal:  Viruses       Date:  2020-08-08       Impact factor: 5.048

9.  Enterovirus D68 Subclade B3 in Children with Acute Flaccid Paralysis in West Africa, 2016.

Authors:  Amary Fall; Ndack Ndiaye; Kevin Messacar; Ousmane Kebe; Mamadou Malado Jallow; Hamid Harouna; Davy Evrard Kiori; Sara Sy; Déborah Goudiaby; Mohamed Dia; Mbayame Ndiaye Niang; Kader Ndiaye; Ndongo Dia
Journal:  Emerg Infect Dis       Date:  2020-09       Impact factor: 6.883

Review 10.  Enterovirus D68 - The New Polio?

Authors:  Hayley Cassidy; Randy Poelman; Marjolein Knoester; Coretta C Van Leer-Buter; Hubert G M Niesters
Journal:  Front Microbiol       Date:  2018-11-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.